Options Ideas: 24 Healthcare Stocks With Bullish Options Sentiment

By
A A A

Are you looking to boost your exposure to the healthcare sector? If so, this may be an interesting starting point for you own analysis.

To construct this list we looked for stocks with three characteristics:

-       Market cap above $300

-       Significant exposure to the healthcare sector

-       Significant increase of the Put/Call ratio over the last two weeks

We also created a price-weighted index of the stocks mentioned below, and monitored the performance of the list relative to the S&P 500 index over the last month. To access a complete analysis of this list's recent performance, click here.

Options traders think these stocks are bound to rally…do you?

Analyze These Ideas (Tools Will Open In A New Window )

1. Access a thorough description of all companies mentioned

2. Compare analyst ratings for all stocks mentioned below 

3. Visualize market cap changes for the top stocks mentioned

List sorted by percentage change of the Put/Call ratio.

1. Volcano Corporation (VOLC): Medical Appliances & Equipment Industry. Market cap of $1.60B. The Put/Call ratio decreased by 63.5%, from 2 to 0.73. Relatively low correlation to the market (beta = 0.62), which may be appealing to risk averse investors. The stock is a short squeeze candidate, with a short float at 7.11% (equivalent to 5.85 days of average volume). The stock has had a good month, gaining 16.19%.

2. GTX Inc. (GTXI): Biotechnology Industry. Market cap of $304.63M. The Put/Call ratio decreased by 62.35%, from 0.85 to 0.32. Relatively low correlation to the market (beta = 0.67), which may be appealing to risk averse investors. The stock is a short squeeze candidate, with a short float at 21.58% (equivalent to 10.46 days of average volume). The stock has had a good month, gaining 13.93%.

3. Lincare Holdings Inc. (LNCR): Home Health Care Industry. Market cap of $2.74B. The Put/Call ratio decreased by 61.54%, from 0.26 to 0.1. Relatively low correlation to the market (beta = 0.63), which may be appealing to risk averse investors. The stock is a short squeeze candidate, with a short float at 10.83% (equivalent to 11.37 days of average volume). The stock has lost 5.9% over the last year.

4. AMAG Pharmaceuticals, Inc. (AMAG): Diagnostic Substances Industry. Market cap of $379.19M. The Put/Call ratio decreased by 51.33%, from 1.13 to 0.55. The stock is a short squeeze candidate, with a short float at 7.67% (equivalent to 7.89 days of average volume). The stock has had a couple of great days, gaining 10.82% over the last week.

5. Acorda Therapeutics, Inc. (ACOR): Biotechnology Industry. Market cap of $1.26B. The Put/Call ratio decreased by 47.44%, from 0.78 to 0.41. Relatively low correlation to the market (beta = 0.73), which may be appealing to risk averse investors. The stock is a short squeeze candidate, with a short float at 17.05% (equivalent to 6.99 days of average volume). Exhibiting strong upside momentum--currently trading 6.64% above its SMA20, 16.4% above its SMA50, and 14.82% above its SMA200. The stock has had a good month, gaining 17.56%.

6. Shire plc (SHPGY): Drug Manufacturers - Other Industry. Market cap of $51.78B. The Put/Call ratio decreased by 45.99%, from 1.37 to 0.74. The stock has gained 50.62% over the last year.

7. Alexion Pharmaceuticals, Inc. (ALXN): Drug Manufacturers - Other Industry. Market cap of $8.70B. The Put/Call ratio decreased by 39.44%, from 0.71 to 0.43. Relatively low correlation to the market (beta = 0.64), which may be appealing to risk averse investors. The stock has gained 82.89% over the last year.

8. NPS Pharmaceuticals, Inc. (NPSP): Biotechnology Industry. Market cap of $803.24M. The Put/Call ratio decreased by 38.89%, from 0.36 to 0.22. Relatively low correlation to the market (beta = 0.77), which may be appealing to risk averse investors. The stock has gained 43.91% over the last year.

9. Kinetic Concepts Inc. (KCI): Medical Appliances & Equipment Industry. Market cap of $4.09B. The Put/Call ratio decreased by 32.76%, from 0.58 to 0.39. Relatively low correlation to the market (beta = 0.77), which may be appealing to risk averse investors. The stock is a short squeeze candidate, with a short float at 7.68% (equivalent to 7.33 days of average volume). The stock has gained 39.83% over the last year.

10. Alnylam Pharmaceuticals, Inc. (ALNY): Biotechnology Industry. Market cap of $416.47M. The Put/Call ratio decreased by 28.57%, from 0.35 to 0.25. The stock is a short squeeze candidate, with a short float at 10.88% (equivalent to 14.77 days of average volume). The stock has lost 38.63% over the last year.

11. Covidien plc (COV): Medical Instruments & Supplies Industry. Market cap of $26.88B. The Put/Call ratio decreased by 26.8%, from 0.97 to 0.71. The stock has gained 33.98% over the last year.

12. Neurocrine Biosciences Inc. (NBIX): Biotechnology Industry. Market cap of $425.04M. The Put/Call ratio decreased by 20.0%, from 0.2 to 0.16. Relatively low correlation to the market (beta = 0.28), which may be appealing to risk averse investors. The stock has had a couple of great days, gaining 7.69% over the last week.

13. DaVita, Inc. (DVA): Specialized Health Services Industry. Market cap of $7.99B. The Put/Call ratio decreased by 18.92%, from 0.37 to 0.3. Relatively low correlation to the market (beta = 0.28), which may be appealing to risk averse investors. The stock has gained 32.94% over the last year.

14. St. Jude Medical Inc. (STJ): Medical Appliances & Equipment Industry. Market cap of $15.81B. The Put/Call ratio decreased by 17.44%, from 0.86 to 0.71. Relatively low correlation to the market (beta = 0.67), which may be appealing to risk averse investors. The stock has gained 32.06% over the last year.

15. VIVUS Inc. (VVUS):
Biotechnology Industry. Market cap of $675.59M. The Put/Call ratio decreased by 15.52%, from 0.58 to 0.49. The stock is a short squeeze candidate, with a short float at 23.03% (equivalent to 7.56 days of average volume). It's been a rough couple of days for the stock, losing 5.93% over the last week.

16. Amedisys Inc. (AMED): Home Health Care Industry. Market cap of $890.58M. The Put/Call ratio decreased by 15.22%, from 0.92 to 0.78. Relatively low correlation to the market (beta = 0.58), which may be appealing to risk averse investors. Might be undervalued at current levels, with a PEG ratio at 0.71, and P/FCF ratio at 7.6. The stock is a short squeeze candidate, with a short float at 21.71% (equivalent to 17.64 days of average volume). The stock is currently stuck in a downtrend, trading -11.91% below its SMA20, -14.87% below its SMA50, and -8.76% below its SMA200. The stock has lost 36.54% over the last year.

17. Achillion Pharmaceuticals, Inc. (ACHN): Biotechnology Industry. Market cap of $426.98M. The Put/Call ratio decreased by 15.09%, from 0.53 to 0.45. Relatively low correlation to the market (beta = 0.4), which may be appealing to risk averse investors. Exhibiting strong upside momentum--currently trading 17.37% above its SMA20, 11.41% above its SMA50, and 58.87% above its SMA200. The stock has had a couple of great days, gaining 7.82% over the last week.

18. MAKO Surgical Corp. (MAKO): Medical Appliances & Equipment Industry. Market cap of $1.35B. The Put/Call ratio decreased by 14.95%, from 1.07 to 0.91. Relatively low correlation to the market (beta = 0.19), which may be appealing to risk averse investors. The stock is a short squeeze candidate, with a short float at 17.08% (equivalent to 8.31 days of average volume). The stock has had a good month, gaining 31.45%.

19. Genomic Health Inc. (GHDX): Medical Laboratories & Research Industry. Market cap of $775.66M. The Put/Call ratio decreased by 14.58%, from 0.96 to 0.82. Relatively low correlation to the market (beta = 0.61), which may be appealing to risk averse investors. The stock is a short squeeze candidate, with a short float at 8.54% (equivalent to 22.56 days of average volume). The stock has gained 79.54% over the last year.

20. Par Pharmaceutical Companies Inc. (PRX): Drugs - Generic Industry. Market cap of $1.20B. The Put/Call ratio decreased by 14.29%, from 0.42 to 0.36. Relatively low correlation to the market (beta = 0.69), which may be appealing to risk averse investors. The stock has gained 21.36% over the last year.

21. Sequenom Inc. (SQNM): Biotechnology Industry. Market cap of $820.22M. The Put/Call ratio decreased by 13.64%, from 0.44 to 0.38. Relatively low correlation to the market (beta = 0.29), which may be appealing to risk averse investors. The stock is a short squeeze candidate, with a short float at 18.63% (equivalent to 8.62 days of average volume). Exhibiting strong upside momentum--currently trading 7.57% above its SMA20, 17.8% above its SMA50, and 24.21% above its SMA200. The stock has had a good month, gaining 21.94%.

22. Thoratec Corp. (THOR): Medical Instruments & Supplies Industry. Market cap of $1.89B. The Put/Call ratio decreased by 11.24%, from 0.89 to 0.79. Relatively low correlation to the market (beta = 0.79), which may be appealing to risk averse investors. The stock is a short squeeze candidate, with a short float at 12.43% (equivalent to 7.4 days of average volume). The stock has lost 22.94% over the last year.

23. Vertex Pharmaceuticals Incorporated (VRTX): Drug Manufacturers - Other Industry. Market cap of $11.28B. The Put/Call ratio decreased by 10.2%, from 0.98 to 0.88. Relatively low correlation to the market (beta = 0.6), which may be appealing to risk averse investors. The stock has gained 58.95% over the last year.

24. Isis Pharmaceuticals, Inc. (ISIS): Drug Manufacturers - Other Industry. Market cap of $875.40M. The Put/Call ratio decreased by 10.0%, from 1 to 0.9. The stock is a short squeeze candidate, with a short float at 12.7% (equivalent to 17.58 days of average volume). The stock has lost 9.94% over the last year.

Data sourced from Schaeffer’s and Finviz. Data sourced on June 6th.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks


Kapitall

Kapitall

More from Kapitall:

Related Videos

Stocks

Referenced

Most Active by Volume

183,639,073
  • $42.32 ▲ 3.85%
82,623,623
  • $15.99 ▼ 22.79%
39,547,942
  • $119 ▲ 1.19%
32,107,751
  • $77.62 ▲ 2.63%
29,684,848
  • $10.60 ▲ 2.02%
27,615,309
  • $24.03 ▲ 0.38%
26,917,669
  • $31.10 ▲ 2.07%
26,464,306
  • $47.75 ▲ 0.59%
As of 11/26/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com